Money Talks: Why weight-loss drugs will reshape the world
Money Talks from The Economist
Impact of Novo Nordisk on Danish Economy
Novo Nordisk, the pharmaceutical giant behind groundbreaking weight loss drugs, has become a cornerstone of the Danish economy, driving growth and preventing recession. The company's success has made it the most valuable company in Europe, with around 3% of Danes employed or benefiting from it. The majority of buyers of Novo Nordisk's weight loss drugs are American, paying over $1,000 per month for treatment. The company's significant USD revenue has influenced Denmark's central bank to keep interest rates low to prevent the currency from appreciating against the euro.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
